On June 9, 2022 RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, reported that they will host a webinar highlighting their RenovoTAMP therapy platform (Press release, Renovorx, JUN 9, 2022, View Source [SID1234615835]). The webinar, "Facing Today’s Challenges in Pancreatic Cancer Treatment: Understanding RenovoRx’s Trans-Arterial Micro-Perfusion Therapy Platform," will be held on Tuesday, June 21st at 8:00 am (ET). To register for this event, click here.
Speakers include Dr. Michael Pishvaian, director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center and an associate professor at the School of Medicine, and Shaun R. Bagai, RenovoRx’s Chief Executive Officer.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
During the presentation, Dr. Pishvaian, who also serves as Study Chair for the Company’s Phase 3 TIGeR-PaC clinical trial, will discuss current available treatment options for pancreatic cancer and why they can fall short of providing an effective solution to fighting this deadly disease. He will also discuss how the TIGeR-PaC study is challenging this treatment paradigm by localizing the delivery of chemotherapy directly to the tumor, and how the RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) therapy platform re-envisions the treatment of pancreatic and other solid tumors with the goal of improving survival and quality of life for patients undergoing chemotherapy. Dr. Pishvaian will also explain the scientific rationale underlying RenovoTAMP’s development. Mr. Bagai will conclude by talking about the Company’s plan for expanding the utility of its innovative therapy platform and its anticipated milestones for the remainder of the year. The virtual presentation will also include a Q & A session.
A recording of this presentation will be posted to the RenovoRx Website Events page when it becomes available.